Recently, the use of the following phenotype categories was suggested by Kratz et al.3: (1) LFS: the presence of a germline P/LP or mosaic TP53 variant in a person with any cancer before age 18 years or who meets established testing criteria (Chompret A or B). The gene discussed is TP53; the disease is cancer.